VB-Watermark-Holdings-logo

VBW is a Perpetual Holding Company
with Unparalleled Access to the MedTech frontier

We are dedicated to building alternative wealth for our Shareholders through improving the well-being of humanity.

Portfolio Entities

Our portfolio approach
fosters synergy among our investments

At VBW, we invest at the forefront of MedTech, supporting our portfolio companies with regulatory and operational expertise. We have a selection of financial tools available to promote their sustainable growth.

Centinel Spine, LLC
ClinicaHealth Inc.
Companion Spine, LLC
MCRA Holdings, LLC
Rocket EMS, Inc.
Spine Biopharma, LLC
Synchron, Inc.
Discover More
VB-Watermark-ABOUT US

ABOUT US

Changing the Game
in MedTech Investments with Regulatory Insight

Viscogliosi Brothers Watermark Holdings was founded in 2022 with a long term vision to build alternative wealth for its Shareholders.

We aim to leverage the regulatory expertise of MCRA, a world class clinical research organization founded by the Viscogliosi Brothers (VB) in 2004, to identify and access innovative opportunities in the MedTech industry.

Our People

Meet Our Team

Investment Strategy

Dedicated to Creating a Portfolio that
Generates Cash Flow while Our Investments Mature

We employ a dynamic asset allocation strategy which serves in maximizing Shareholder value on a risk adjusted basis. The strategy has 3 distinct pillars:

Venture Capital

Through capitalizing on our organic ties with MCRA, world’s renowned Clinical Research Organization, we identify and invest in early-stage ventures that have ground-breaking disruptive technologies or dramatic cost cutting solutions with high gross margin and market capture potential prior to achieving inflection points on their path to regulatory (FDA) approval.

Growth Opportunities

We co-invest with Viscogliosi Brothers’ other investment vehicles to secure control rights in late stage revenue generating Companies with a clear path to exit within an 18-24 month time frame.

Income Generation

We believe that one of the unique features that differ us from the industry is our capability to create predictable cashflow for our Shareholders. We accomplish this by extending non-dilutive loans to MedTech companies that exhibit strong commercial potential. Some of the strategies we employ include accounts receivable factoring, instrument leasing, inventory and royalty financing, enabling us to distribute returns derived from our financing endeavors.

VB-Watermark-Affiliates

Affiliates

MCRA

Founded by the Viscogliosi Brothers in 2004, MCRA is the leading Clinical Research Organization (CRO), serving the MedTech industry worldwide.

Discover More
VB-Watermark-Strategic Partners

Strategic Partners

United Capital
Funding

Founded in 1997, United Capital Funding Group LLC is a leading provider of working capital finance in the United States with a balance sheet of $3 billion. Today, United Capital is a wholly owned subsidiary of Gulf Coast Bank & Trust, a FDIC-insured community bank.

Discover More
VB-Watermark-Solution Partners

Solution Partners

We Put Strong Emphasis on
External Enterprise Model

We work with the best of class experts around the globe regarding tax, audit, accounting, legal and due diligence.

Discover More

PRESS RELEASES

Our Portfolio Milestones

Most recent updates from our portfolio entities

CONTACT US

We Welcome
Your Inquiries

Connect with our global team of experts.

Contact Form